Detalhe da pesquisa
1.
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis.
Br J Cancer
; 130(2): 269-274, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030749
2.
The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations.
Hered Cancer Clin Pract
; 22(1): 7, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38741145
3.
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
Cancer
; 129(6): 901-907, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571512
4.
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
Breast Cancer Res Treat
; 201(2): 257-264, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432545
5.
Iron Status and Associated Factors among Canadian Women: Results from the Canadian Health Measures Survey.
J Nutr
; 153(3): 781-797, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788041
6.
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.
BJOG
; 130(12): 1437-1450, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37132126
7.
Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer.
Int J Mol Sci
; 24(18)2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762691
8.
Impact of germline mutations in cancer-predisposing genes on long-term survival in patients with epithelial ovarian cancer.
Br J Cancer
; 127(5): 879-885, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710751
9.
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol
; 164(3): 514-521, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063280
10.
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study.
Int J Gynecol Cancer
; 32(1): 41-47, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845040
11.
Beyond the pill: contraception and the prevention of hereditary ovarian cancer.
Hered Cancer Clin Pract
; 20(1): 21, 2022 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35668475
12.
Delineating the role of osteoprotegerin as a marker of breast cancer risk among women with a BRCA1 mutation.
Hered Cancer Clin Pract
; 20(1): 14, 2022 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35418083
13.
An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool.
Cancer
; 127(17): 3183-3193, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077552
14.
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat
; 187(2): 515-523, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423179
15.
Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
Int J Cancer
; 147(5): 1245-1251, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037528
16.
Iron intake, oxidative stress-related genes and breast cancer risk.
Int J Cancer
; 147(5): 1354-1373, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32022258
17.
Blood arsenic levels and the risk of familial breast cancer in Poland.
Int J Cancer
; 146(10): 2721-2727, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31348523
18.
Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol
; 159(3): 820-826, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010967
19.
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriers.
Int J Gynecol Cancer
; 30(6): 825-830, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32354794
20.
Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case-control study.
Breast Cancer Res Treat
; 174(3): 741-748, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30603998